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ABSTRAK 
 
Pengenalan: Terdapat garis panduan yang bercanggah berkaitan dengan penggunaan 
antibiotik bagi pesakit yang menjalani kaedah rawatan Extracorporeal Shock Wave 
Lithotripsy (ESWL),  terutama pesakit yang ujian kultur air kencing steril sebelum rawatan 
ESWL. Kajian ini telah dijalankan untuk menilai keberkesanan penggunaan antibiotik pada 
pesakit dengan jangkitan air kencing tanpa simptom dan pesakit dengan air kencing steril 
sebelum ESWL. 
Bahan dan Kaedah: Dalam ujian ini, 224 pesakit dengan batu ginjal telah diperiksa dengan 
ujian kultur air kencing sebelum ESWL. Pesakit-pesakit ini dibahagikan kepada 2 kumpulan 
utama berdasarkan keputusan ujian kultur air kencing, iaitu kumpulan jangkitan air kencing 
tanpa simptom dan kumpulan air kencing steril. Setiap kumpulan masing-masing dirambang 
secara rawak kepada kumpulan intervensi (diberi antibiotik) dan kumpulan kawalan (tiada 
antibiotik). Ubat Ciprofloxacin 500mg diberi setengah jam sebelum ESWL kepada kumpulan 
intervensi. Pesakit kemudian diikuti untuk simptom jangkitan air kencing dan ujian kultur air 
kencing selepas satu minggu. 
Hasil: Untuk pesakit dengan jangkitan air kencing tanpa simptom sebelum ESWL, 
penggunaan antibiotik mengurangkan kejadian simptom jangkitan air kencing selepas ESWL 
daripada 45.5% kepada 13.0% (p = 0.016). Untuk pesakit dengan air kencing steril sebelum 
ESWL, kejadian simptom jangkitan air kencing selepas ESWL tidak berbeza antara 
kumpulan intervensi dan kumpulan kawalan. Kelaziman jangkitan air kencing tanpa simptom 
untuk pesakit yang menjalani ESWL adalah 20.1%. Escherichia Coli adalah bakteria yang 
paling biasa dikultur (43.6%), diikuti oleh Klebsiella Pneumoniae (12.7%). 
x 
 
Kesimpulan: Ujian kultur air kencing rutin adalah disyorkan untuk pesakit yang dijadualkan 
untuk ESWL. Penggunaan antibiotik adalah disyorkan kepada pesakit dengan jangkitan air 
kencing tanpa simptom sebelum ESWL, kerana ia mungkin dapat mengurangkan risiko 
simptom jangkitan. 
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ABSTRACT 
Introduction: There are conflicting guidelines with regards to usage of antibiotic for patients 
undergoing Extracorporeal Shock Wave Lithotripsy (ESWL), especially for patients with 
sterile urine before procedure. This study was performed to evaluate the efficacy of antibiotic 
usage in patients with asymptomatic urinary tract infection (UTI) and in patients with sterile 
urine prior to ESWL. 
Materials and Methods: In this randomized controlled trial, 224 patients with renal and 
ureteric stones were examined for bacteriuria (positive urine culture) prior to ESWL. These 
patients were classified into 2 main groups based on their urine culture result, as 
asymptomatic UTI group and sterile urine group. Each of these groups were then randomised 
to intervention (given antibiotic) group and control (no antibiotic) group. Tablet 
Ciprofloxacin 500mg were given half hour prior to ESWL for intervention group. Patients 
were then followed for symptoms of UTI and urine culture after one week. 
Results: For patients with pre-ESWL asymptomatic UTI, antibiotic usage significantly 
reduced incidence of post-ESWL symptomatic UTI from 45.5% to 13.0% (p=0.016). For 
patients with pre-ESWL sterile urine, incidence of post-ESWL symptomatic UTI does not 
differ between intervention and control group. The prevalence of asymptomatic UTI in 
patients undergoing ESWL is 20.1%. Escherichia Coli was the most commonly isolated 
bacteria (43.6%), followed by Klebsiella Pneumoniae (12.7%). 
Conclusion: Routine urine culture is recommended for patients scheduled for ESWL. 
Antibiotic usage is recommended in patients with pre-ESWL asymptomatic UTI, as it may be 
beneficial in reducing risk of symptomatic infection. 
 
1 
 
1.0 INTRODUCTION 
Extracorporal Shock-Wave Lithotripsy (ESWL) was first introduced in West Germany 
in early 1980s by Dornier Medizintechnik GmbH (now known as Dornier MedTech 
Systems GmbH). (Chow and Streem, 2000) This technology has since revolutionized 
the treatment for urolithiasis and has gained rapid acceptance worldwide because of its 
ease of use, minimally invasive nature and high efficacy in treating renal and ureteral 
stones.  
1.1 Principles of ESWL 
ESWL generates shockwave underwater (which serves as coupling mechanism), and 
then directed onto a focal point. The patient is positioned on a treatment table whereby 
the stone is localised using an imaging system. The focal point of the shockwave is 
positioned by moving the shockwave source or the patient. A few thousand shockwaves 
are generated and applied at a frequency of 60 to 120 waves per minute, resulting in 
treatment time of around one hour. Stone position is routinely checked using the 
imaging system throughout the procedure. (Köhrmann, 2005) 
1.2 The ESWL Machine 
All ESWL machines are composed of 4 essential parts – shockwave generator, focusing 
system, localisation system, and shockwave coupling. (Köhrmann, 2005; Andrade et al., 
2006):  
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F1 = 1st Focal Point; F2 = 2nd Focal Point 
Fig 1: The Shockwave Machine (adapted from Andrade, 2006) 
(1) Shockwave generator: The shockwave is created in the 1st focal point at the centre 
of an ellipsoid reflector (F1) and are directed to a second focal point (F2) inside the 
patient (at the stone). This focal point (F2) is the area of maximum shockwave 
focus. (Andrade et al., 2006) There are 3 main types of generators, namely 
electrohydraulic, electromagnetic and piezoelectric. (Köhrmann, 2005) The ESWL 
machine in HUSM uses a proprietary technology called electroconductive, which is 
developed by EDAP-TMS in partnership with the French Medical Research 
Institute. (EDAP-TechnoMed, 2008) 
a. Electrohydraulic generator is the original method of shockwave generation 
which is based on spark-gap technology. The electrode is positioned within a 
water-filled container. Electrical current that passes across the spark-gap 
electrode causes an evaporation of water bubble, which expands and 
immediately collapses, resulting in high pressure wave. The ellipsoid 
reflector focuses the shockwave to a focal point (F2), whereby it reaches 
Ellipsoid Reflector 
(Focusing System) 
 
Electrode  
(Shockwave generator) 
Water  
(Coupling Medium) 
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high stone disintegrative capacity. (Köhrmann, 2005) However, this 
technology has high energy density at skin-entry point of the shockwaves 
which often causes pain, thereby necessitating deep sedation or anaesthesia 
for effective stone disintegration. (Buizza et al., 1995; Köhrmann, 2005) The 
burning of electrodes is also not consistent, resulting in variation of different 
shockwaves applied in the same setting. Moreover, the electrodes need to be 
changed after a few treatments, resulting in higher maintenance cost of 
operating electrohydraulic ESWL machine. This technology is used in 
Dornier HM3 (Human Machine 3). (Köhrmann, 2005) 
b. Electromagnetic generators use a high voltage that is applied to an 
electromagnetic coil, similar to loudspeakers. Electrical current that passes 
into the electromagnetic coil creates a transient magnetic field around the 
coil assembly. The magnetic field induces strong currents to the adjacent 
metallic membrane, which repels from the coil. Since the electromagnetic 
coil and metallic membrane are immersed in water, a pressure wave is 
formed which propagates to the parabolic focusing reflector. The parabolic 
reflector focuses the shockwave to a focal point (F2). The advantage of this 
technology is that the shockwaves produced are constant and has a smaller 
focal point with higher peak energy. However, this technology also causes 
pain, albeit lesser than electrohydraulic technology due to a smaller focal 
point. Example of lithotripters that utilise this technology are Dornier Doli 
and Lithostar Siemens. (Köhrmann, 2005; Grasso and Green, 2012) 
c. Piezoelectric generators consist of multiple piezoelectric ceramic crystals set 
in a water-filled container. Electrical current that passes through a 
piezoelement stimulates alternating stress/strain changes in the material, 
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resulting in shockwave production. These piezoelements are aligned in a 
hemispherical shape that directly focuses the propagation of pressure waves 
to a very small focal point. The resultant shockwave causes low level of pain 
and can be applied without sedation. The disadvantage of this technology is 
the need for a larger diameter of the shockwave source as well as limited 
total energy in the focus point. This technology is used in PiezoLith by 
Wolff. (Köhrmann, 2005; Grasso and Green, 2012) 
Electroconductive generators are a proprietary technology developed by EDAP-
TMS, tout as a fourth generation lithotripter. It is an improved technology over 
electrohydraulic generator whereby the patented electrode is encapsulated in a 
highly conductive solution (electrolyte). Electrical current that passes through the 
electrode produces microbubbles, that expand and collapse, generating shockwave. 
The shockwave generated is more consistent and the ellipsoidal reflector focuses the 
pressure waves to a focal point (F2). The automatic pressure regulator, incorporated 
within the electrode, ensures consistently higher peak energy at a small focal point. 
As with electrohydraulic generators, the patented electrodes need to be changed 
after a few treatments, which contributes to a higher operational cost. Example of 
lithotripter that uses this technology is Sonolith by EDAP-TMS. (EDAP-
TechnoMed, 2008) 
(2) Shockwave focusing system: This is a focusing system to direct and concentrate the 
shockwave energy at the stone (F2). The basic geometry of the reflector is ellipsoid. 
Different shockwave generators use different focusing systems. Electrohydraulic 
and electroconductive system uses metal ellipsoid that directs the energy created. 
Electromagnetic systems uses cylindrical reflector (Storz system) or acoustic lens 
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(Siemens system). Piezoelectric systems uses ceramic crystals arranged in a 
hemispherical shape. (Grasso and Green, 2012) 
(3) Urinary stone imaging or localization system: There are 2 methods of localising the 
stone – fluoroscopy and ultrasonography. (Köhrmann, 2005) 
Flouroscopy uses ionizing radiation to visualise stone. The advantage of fluoroscopy 
is that the stone can be visualised throughout the entire urinary tract and is easy to 
use. The disadvantages include usage of inonizing radiation, inability to visualise 
radiolucent stones, and has a higher cost of maintenance. (Grasso and Green, 2012) 
Ultrasonography uses acoustic waves to localize stones. Advantages are the ability 
to visualise radiolucent stones and real time monitoring of procedure without 
ionizing radiation. However, the disadvantages are that visualisation of stone is 
operator dependent, small stones may be difficult to visualise and there is limitation 
in localising middle and lower ureter due to interposed air-filled intestinal loops. 
(Grasso and Green, 2012) 
(4) Shockwave coupling mechanism 
In transmission of wave, energy is lost at interfaces that differ in density. Therefore, 
a coupling system is used to minimize the loss of energy as the waves pass through 
the skin surface. The usual medium used is water because water has a similar 
density to soft tissue and is readily available. In first generation lithotripters 
(Dornier HM3), patients are placed in a water bath. In second, third and fourth 
generation lithotripters, small water-filled drums with silicone membrane are used 
which is in contact with patient’s skin. (Grasso and Green, 2012) However, this 
change of ideal coupling using water bath in Dornier HM3 lithotripter to coupling 
cushions, necessitates the use of gel as it enables a tight bond between coupling 
cushions and patient’s skin.  As such, with the water cushion, the quality of coupling 
6 
 
has become a critical factor that determines the success of stone fragmentation. 
Lower viscosity and bubble-free gel are associated with better stone fragmentation 
as it provides significantly better coupling quality. (Rassweiler et al., 2011) 
1.3 Evolution of Shockwave Lithotripters 
Engineers at Dornier, a German Aircraft manufacturer, were studying the effects of 
shockwaves generated by supersonic aircraft. They observed that the shape of the 
aircraft could direct shockwaves onto other parts of the aircraft, accelerating metal 
fatigue. (Chow and Streem, 2000) In 1974, clinical research on effects of shockwave on 
stone disintegration was conducted between Dornier and the Ludwig Maximillians 
University in Munich, Germany. (Bach and Buchholz, 2011) As a result of that, the first 
lithotripter was produced by Dornier. In February 1980, the first patient was treated by 
Christian Chaussy with a prototype machine Dornier HM1 (Human Model 1) in 
Munich, Germany. (Chaussy et al., 1982) Subsequently in 1984, Dornier launched 
HM3, the first commercially produced lithotripter. In this model, both patient and 
generator are submerged in a metal water tank. The generator is focused using the 
ellipsoid metal water tank. The electrodes get worn out every 200-300 shocks, and the 
patient had to be taken out of the water tank to change the electrodes. Despite being 
outdated, Dornier HM3 is still one of the most effective lithotripters and is the standard 
to which other newer shockwave generators are compared to. (Chow and Streem, 2000; 
Pes et al., 2010; Grasso and Green, 2012) 
Second-generation lithotripters use electromagnetic or piezoelectric generators. The 
coupling device has also improved into a silicon-encased water cushion that interfaced 
with the patient’s body. This design simplifies positioning of the patient. The advent of 
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second generation lithotripters brought on the era of dry or tubless lithotripsy. (Winters 
and Macaluso Jr, 1995; Chow and Streem, 2000; Köhrmann, 2005; Pes et al., 2010) 
Third generation lithotripters are improvements over second-generation lithotripters in 
the direction of portability; integration of both fluoroscopic and ultrasonographic 
imaging system; and minimising pain to the patient by producing smaller focal zone. 
However, smaller focal zone has its own disadvantage. During respiration, the stone 
may move in and out of the focal zone, thus decreasing effectiveness of stone 
fragmentation. (Chow and Streem, 2000; Köhrmann, 2005; Pes et al., 2010) 
Electroconductive lithotripters are claimed by TechnoMed Medical System (TMS) as a 
fourth generation lithotripters. This is an improvement over electrohydraulic 
technology, whereby shockwaves are more consistent and electrodes last longer. 
(EDAP-TechnoMed, 2008) 
1.4 Pathophysiology of Stone Fragmentation 
A stone is fragmented when the shockwave force is greater than the tensile strength of 
the stone. Fragmentation occurs through a combination of mechanical and dynamic 
forces on stones such as cavitation, shearing and spalling. The most important force is 
thought to be cavitation. The destructive forces generated when the cavitation bubbles 
collapse are responsible for the ultimate stone fragmentation. (Skolarikos et al., 2006) 
As a shockwave is propagated through a coupling medium (water), it loses very little 
energy until it crosses to another medium with a different density. If the medium it 
crosses is denser, compressive force is produced on the new medium. If the medium is 
less dense, tensile stress is produced. When the wave hits the anterior surface of a stone, 
the change in density from low to high density produces compressive force, causing 
fragmentation. As the wave passes through the stone to the posterior surface of the 
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stone, the change from high to low density produces tensile stress, again causing 
fragmentation. In cavitation, the negative pressure tail of acoustic pulse produces small 
gaseous bubbles (cavities) in the urine surrounding the stone. These bubbles 
immediately implode, generating powerful microjets of fluid towards the surface of the 
stone causing fracture of the stone. Higher shockwave rates causes greater cavitation 
intensity, but lowers the amplitude and duration of negative pressure in the acoustic 
pulse. This explains why stone fragmentation is reduced in high shockwave frequency 
(120 shocks per minute) as compared to low shockwave frequency (30-60 shocks per 
minute); and also why tissue damage increases at a high shockwave frequency. (Pes et 
al., 2010) 
1.5 Current Guideline on Urolithiasis 
Current treatment options for renal and ureteral stones include conservative 
management (medical expulsion therapy), ESWL, endoscopic methods (rigid or flexible 
ureteroscopic lithotripsy) and percutaneous techniques (percutaneous nephrolithotomy).  
European Association of Urology (EAU) guidelines on urolithiasis (Tiselius et al., 
2008) suggests active treatment for all urinary stones greater than 6-7mm size. For renal 
stone, ESWL is the first recommended option for stones ≤ 20mm. For ureteral stone, 
ESWL is the first treatment option for proximal ureteric stone, and in combination with 
ureteroscopy (URS) for middle and distal ureteric stones.  
Absolute contraindications for ESWL include pregnancy, severe skeletal malformation, 
aortic or renal artery aneurysm, uncontrolled blood coagulopathy, and uncontrolled 
urinary tract infections. 
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1.6 Complications of ESWL 
Complications of ESWL can be categorized into immediate complications and delayed 
complications. 
1.6.1 Immediate Complications 
Immediate complications are mainly related to infectious complications and effects of 
ESWL on tissue.  
ESWL can cause trauma to thin-walled vessels in the kidneys and adjacent tissues, 
which result in haemorrhage, release of cytokines and inflammatory cellular mediators; 
and infiltration of tissue by inflammatory response cells. This may lead to short-term 
complications and to formation of scar; possible chronic loss of tissue function. Renal 
trauma and vascular disruption associated with ESWL may allow bacteria in urine to 
enter the bloodstream. Moreover, when infected calculi are destroyed, bacteria are 
released from the stone into the urine and may be absorbed systematically. (Skolarikos 
et al., 2006).  
Histopathological evaluation after ESWL in animal and human kidney showed 
endothelial damage to mid-size arteries, veins and glomerular capillaries. (Karlsen et 
al., 1991; Recker et al., 1992) The thin-walled arcuate veins in corticomedullary 
junction are especially susceptible to shockwave damage and are mainly responsible for 
haemorrhage, haematuria and haematoma. (Karlsen et al., 1991) Although these are 
usually a focal process, healing in the following days, ESWL-induced acute renal 
damage can result in severe nephron injury, microvasculature, and surrounding 
interstitium. (Delvecchio et al., 2003) These injuries may have long-term effect on renal 
function.  
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Gross haematuria is the most common clinical manifestation of renal trauma, which 
resolves in a few days. The incidence of intrarenal, subcapsular, and perirenal 
haematoma is reported to be around 4.1% of all post-ESWL patients. However, almost 
all of these patients have previously unrecognised or untreated bleeding diathesis, such 
as haemophilia and warfarin use. (Dhar et al., 2004; Pes et al., 2010) Hence, 
uncorrected bleeding disorders are absolute contraindication for ESWL treatment. 
Cardiac arrhythmias have an incidence of 11 – 59%, usually presenting as self-limiting 
unifocal premature ventricular contractions.  Evidence of myocarfial injury is extremely 
rare. The incidence can be reduced by gating the shockwave to the electrocardiogram 
(ECG) pulse. (Zanetti et al., 1999) Gating of shockwave refers to triggering of 
shockwave to the R-wave in the ECG. Ungated ESWL can still be performed, but the 
incidence of arrhythmia increases. (Winters and Macaluso Jr, 1995) Presence of 
pacemaker is not contraindication for ESWL. However, the treatment should be 
supervised by cardiologist. Dual-chamber pacemakers should be reprogrammed to 
single-chamber mode. (Albers et al., 1995) Abdominal aneurysm rupture and major 
vein thrombosis after ESWL have been reported but is rare. (Neri et al., 2000; 
Skolarikos et al., 2006) 
Gastrointestinal complications are rare and accounts for only 1.81% of post-ESWL 
patients in a review series. Reported complications include small bowel and colonic 
perforation; ureterocolic fistula; gastrointestinal anastomosis dehiscence; caecal ulcers; 
colonic erythema; intestinal bruising and haematomas; per rectal bleeding; pancreatitis; 
pancreatic haematoma and abscess formation; liver and spleen subcapsular 
haematomas; and ileus. (Maker and Layke, 2004) 
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1.6.2 Delayed Complications 
Pregnancy is an absolute contraindication for ESWL because of the potential disruptive 
effects on the foetus, resulting in foetal damage or foetal death. (Ohmori et al., 1994) 
Long-term follow-up after ESWL failed to show any significant renal function 
impairment, even in children, when ESWL is correctly administered. (Brinkmann et al., 
2001; Skolarikos et al., 2006) 
Randomized Controlled Trials also failed to demonstrate any evidence that ESWL 
causes hypertension. (Jewett et al., 1998; Elves et al., 2000) 
Evidence has showed that ESWL does not cause severe or permanent damage to 
testicular or ovarian function. Therefore, fertility is not affected by ESWL. (Vieweg et 
al., 1992; Basar et al., 2004) 
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2.0 LITERATURE REVIEW 
ESWL is associated with remarkably few complications. One of the feared, although 
rare (0.1 – 1.5%), complications associated with ESWL is urosepsis, which occurs when 
bacteria are released from calculi as they fragmented. (Pearle and Roehrborn, 1997) 
2.1 Role of Antibiotics in Pre-ESWL Asymptomatic UTI Patients 
Every literature reviewed agrees unanimously that presence of asymptomatic UTI 
before ESWL is associated with higher risk of symptomatic UTI and urosepsis. The 
incidence of developing symptomatic UTI is 7.9% - 11%. (Matsumoto et al., 2007) 
Therefore, antibiotics are recommended for this group of patients. However, the 
duration of antibiotics may differ, ranging from prophylactic dose (Matsumoto et al., 
2007) or duration of more than 24 hours (Wolf Jr et al., 2008), depending on patient 
condition.  
2.2 Role of Antibiotics in Pre-ESWL Sterile Urine Patients 
The use of preoperative antimicrobial agents in high risk patients is not controversial. 
(Pearle and Roehrborn, 1997) High risk patients refer to patients with risk factors that 
predisposes a higher likelihood of developing urinary tract infection or urosepsis as 
compared to patients who do not have these risk factors. These risk factors are patients 
with infective stones; internal stent; indwelling catheter; nephrostomy tubes; history of 
symptomatic urinary tract infections or bacteraemia after ESWL; and those undergoing 
pre-ESWL endoscopic instrumentation; (Skolarikos et al., 2006; Matsumoto et al., 
2007; Grabe et al., 2009) 
However, the routine use of antimicrobial prophylaxis in low risks patients with sterile 
preoperative urine has been widely debated. (Pearle and Roehrborn, 1997) Current 
13 
 
guidelines across different countries cannot agree on the use of prophylaxis antibiotics 
prior to ESWL.  
The American Urological Association’s guideline on Urologic Surgery Antimicrobial 
Prophylaxis states that any stone manipulation including shock-wave lithotripsy 
increases the risk of bacteraemia. It recommends antibiotic prophylaxis in all patients 
undergoing shock-wave lithotripsy. The antibiotic of choice is Flouroquinolone and 
Trimethoprim-Sulfamethoxazole (TMP-SMX). Duration of antibiotic given is less than 
24 hours. (Wolf Jr et al., 2008).  
European Association of Urology’s Guidelines on Urological Infections states that no 
standard prophylaxis is recommended, except in high risks patients. This is because of 
the low frequency of infections after ESWL and contradictory findings on papers. It 
recommends TMP-SMX, 2nd or 3rd Generation Cephalosporin as antibiotics of choice. 
(Grabe et al., 2009)  
The Japanese Urological Association Guidelines for Prevention of Perioperative 
Infections in Urological Field states that for patients with pre-ESWL sterile urine, the 
incidence of asymptomatic bacteriuria and symptomatic UTIs after ESWL are 
approximately 10% (0 – 24%) and 3% (0 – 10%). Based on such evidence, possibility 
of clinically significant infections such as symptomatic UTIs or bacteraemia is low 
without antimicrobial prophylaxis. Hence, the guideline states that antimicrobial 
prophylaxis is not necessary for patients with pre-ESWL sterile urine, except for high 
risk patients. Recommended antibiotics are 2nd generation cephalosporin or 
flouroquinolones. (Matsumoto et al., 2007) 
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2.2.1 Evidence For Antibiotic Prophylaxis 
Pearle et al conducted a meta-analysis and cost analysis of eight randomised controlled 
trials (RCTs), comparing antibiotics vs no antibiotics in patients with pre-ESWL sterile 
urine. In this meta-analysis, it is concluded that the use of antibiotic prophylaxis in 
patients with pre-ESWL sterile urine is beneficial and reduces the post-ESWL 
complication rate. All literatures clearly demonstrate superiority of prophylaxis over no 
treatment. Overall risk of developing UTI after ESWL is 2% in antibiotic group, as 
compared to 7% in no antibiotic group. The cost analysis shows that prophylaxis is cost-
effective, provided that prophylaxis is given in the form of SMX/TMP or ciprofloxacin. 
Moreover, the cost of prophylactic antibiotic represents only a small fraction of the total 
cost of ESWL treatment. (Pearle and Roehrborn, 1997) 
A large retrospective study was conducted at a Stone Clinic, Institute of Urology and 
Transplantation, Pakistan which spans over 17 years of experience (1990 – 2007) 
amounting to 21214 subjects undergoing ESWL, of which 35264 sessions of ESWL 
were conducted. Between the year 1990 – 2000, no antibiotic was given and the 
reported post-ESWL complication rate (including UTI) was 16.2%. Between the year 
2001 – 2007, antibiotic prophylaxis was given, and the reported post-ESWL 
complication was significantly lower at 3.5%. Hence, this urology centre practises 
routine antibiotic prophylaxis for all pre-treatment sterile urine patients. (Hussain et al., 
2009) 
One German RCT by Claes et al, involving 181 patients with pre-ESWL sterile urine 
given amoxicillin/clavulanate prior to ESWL, demonstrated significant reduction in 
incidence of symptomatic UTI in antibiotic group (0%) as compared to no antibiotic 
group (7.6%). (Claes et al., 1989) 
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Similar findings were made by another German study. The RCT involving 50 patients 
with pre-ESWL sterile urine noted incidence of bacteriuria is 32% in no antibiotic group 
as compared to 0% in antibiotic group. This study concluded that the antibiotic 
Enoxacin can significantly reduce infection after ESWL. (Knipper et al., 1989) 
2.2.2 Evidence Against Antibiotic Prophylaxis 
A research group in Netherland, which conducted a systemic review of 4 RCTs on 
ESWL, showed a fair amount of evidence that the post-ESWL rate of bacteriuria and 
symptomatic UTIs is low and use of antibiotic prophylaxis does not decrease this 
incidence. Therefore, there is no need for antibiotic prophylaxis in uncomplicated 
patients with pre-ESWL sterile urine. (Bootsma et al., 2008) 
An RCT conducted in Sweden by Petterson et al, on patients with pre-ESWL sterile 
urine, shows no significant difference between TMP-SMX group, Methenamine group 
and no antibiotic group. The study concluded that antibiotics during ESWL is 
unnecessary. About 30% of the patients in this study has ureteric stent. The researchers 
noted that patients with ureteric stent did not present with more infectious complications 
than those without. (Pettersson and Tiselius, 1989) 
Ilker et al conducted an RCT in Turkey involving 311 patients with pre-ESWL sterile 
urine. Results from this study showed no significant difference between Ofloxacin 
group and no antibiotic group. Antibiotic prophylaxis appears to be unnecessary. 
However, the researchers also rational that for patients with increased risk of infection, 
such as infected stones, multiple large stones and perioperative urologic manipulation, 
prophylactic antibiotics should be used due to higher incidence of infection. (Ílker et al., 
1995) 
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Similar results were noted in a Netherland study by Bierkens et al. This RCT involving 
177 patients with pre-ESWL sterile urine noted that after 2 weeks and 6 weeks post 
ESWL, 20% and 23% of patients developed bacteriuria. However, there is no statistical 
differences between antibiotic and no antibiotic group. This study concluded that 
antibiotic is not necessary for pre-ESWL sterile urine patients. The study was ended 
after interim analysis because of no differences between placebo and antibiotic 
prophylaxis group. (Bierkens et al., 1997) 
The most recent study was conducted in Iran between 2004 - 2006. This study, an RCT 
involving 150 patients with pre-ESWL sterile urine, showed no significant effectiveness 
of antibiotics on prevention of UTI after ESWL. The Post-ESWL UTI was 14% 
(SMX/TMP group), 10% (nitrofurantoin group) and 14% (Placebo group). 
(Ghazimoghaddam et al., 2011) 
A systemic review done in Greece based on 25 years of medline data from 1980 until 
2004, concluded that the role of routine prophylactic antibiotics is controversial. While 
some studies show prophylaxis antibiotics demonstrate significant decrease in post-
ESWL UTI, some other studies have demonstrated no advantage of prophylactic 
antibiotics. The study also identified pre-existing UTI, infected calculi, multiple stones, 
staghorn stones, history of recurrent UTIs, urinary obstruction and instrumentation at 
time of ESWL as predisposing factors for post-ESWL UTI. (Skolarikos et al., 2006) 
2.3 Justification for this Study 
In HUSM, the current practice is no antibiotic for all patients undergoing ESWL, 
regardless if these patients have pre-existing bacteriuria or sterile urine prior to 
procedure. Urine culture is not taken prior to and after ESWL, unless patient complains 
of symptomatic UTI before or after procedure. This is not an uncommon practice in 
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Malaysia as Urology centres in Hospital Pulau Pinang, Hospital Selayang, Hospital 
UKM and Hospital Kuala Lumpur also do not routinely test urine for infection or give 
antibiotics prior to ESWL. However, there is no study in Malaysia to debate on such 
issue.  
The low incidence of post-ESWL UTI is frequently quoted as a reason not to start 
antibiotics prophylaxis. However, such data applies to the western population or 
developed countries whereby the incidence is low around 5%. Studies in other countries 
such as the Middle East show a higher incidence of around 14% to as high as 16% in 
Pakistan. (Hussain et al., 2009; Ghazimoghaddam et al., 2011) The trend is higher in 
developing countries as compared to developed countries. This may be due to the higher 
rate of infective stones in developing countries. In Kelantan, the demographics of stones 
are 38.1% uric acid stones, 31.6% calcium oxalate stones, 27.1% struvite stones and 
3.2% apatite stones. (Saiful, 2010) Hence, this study will investigate whether with 
antibiotic, the incidence of post-ESWL UTI can be significantly reduced in urology 
patients in HUSM. 
2.4 Rationale for Using Ciprofloxacin 
The most common organism encountered in a urine sample is E. Coli, followed by 
Klebsiella and Staphylococcus Aureus. (Nazmi et al., 1997) In Malaysia, E. Coli 
accounts for 50.5% while Klebsiella accounts for 31.8% of bacteria isolated from urine 
sampling. (Williams et al., 1989) 
Cost-analysis shows that prophylaxis is cost-effective, provided that prophylaxis is 
given in the form of oral SMX/TMP or oral Ciprofloxacin. (Pearle and Roehrborn, 
1997) 
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Foreign data report increasing resistance rates to TMP-SMX.  In a 1999 study of 202 
laboratories in the US, overall resistance rates for TMP-SMX among E. Coli isolates 
was 16.8% (range 7.4%-33.3%) and 1.7% for ciprofloxacin. (Karlowsky et al., 2001) In 
an interim report from 505 centres in 16 European countries, resistance to TMP-SMX 
among E. Coli isolates was 14.6% and 2.9% for ciprofloxacin. (Kahlmeter, 2000) 
A local study done in Klang Valley by Institue of Medical Research, between August 
1991 until June 1993, collected a total of 2823 specimens for analysis of antimicrobial 
resistance pattern. In this study, it is noted that E. Coli has 0% resistance rate to 
ciprofloxacin. (Cheong et al., 1995) 
Oral Ciprofloxacin takes 0.5 to 2 hours to achieve peak plasma concentration while oral 
TMP/SMX takes 1-4 hours to achieve peak plasma concentration. Hospital cost of oral 
ciprofloxacin is RM0.25 per tablet of 250mg strength, while oral Bactrim costs RM0.47 
per tablet of 400mg strength. Choice of oral Ciprofloxacin 500mg dosage was given 
because it is the recommended dose for prophylaxis against UTI. 
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3.0 OBJECTIVES 
3.1 General Objective 
To determine the association between antibiotic usage and post-ESWL urinary tract 
infection in patients, outcome based on urine culture. Bacterial count in the urine of 105 
or more per ml, confirms the diagnosis of UTI. 
3.2 Specific Objectives 
(1) To compare the outcome of post-ESWL UTI between antibiotic group and no 
antibiotic group in patients with pre-ESWL asymptomatic UTI. 
(2) To compare the outcome of post-ESWL UTI between antibiotic group and no 
antibiotic group in patients with pre-ESWL sterile urine. 
(3) To determine the prevalence of asymptomatic UTI in patients undergoing 
ESWL. 
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4.0 HYPOTHESIS 
4.1 Null Hypothesis: 
There is no significant difference between antibiotic group and no antibiotic group in 
patients with pre-ESWL asymptomatic UTI and in patients with pre-ESWL sterile 
urine. 
4.2 Alternative Hypothesis: 
There is significant difference between antibiotic group and no antibiotic group in 
patients with pre-ESWL asymptomatic UTI and in patients with pre-ESWL sterile 
urine.  
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5.0 DEFINITIONS 
Definitions of urinary tract infection (Teresa C. Horan and Atlanta, 2008) 
a) Symptomatic Urinary Tract Infection (UTI)  
Patient has at least ONE of the following signs or symptoms with no other 
recognized cause: fever (>38°C), urgency, frequency, dysuria, suprapubic 
tenderness,  
and 
urine culture of ≥105 microorganisms per cc of urine with no more than 2 
species of microorganisms. 
b) Asymptomatic bacteriuria / UTI 
Patient has no clinical evidence of infection 
and  
urine culture of ≥105 microorganisms per cc of urine with no more than 2 
species of microorganisms. 
c) Sterile Urine 
No growth on urine culture 
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6.0 METHODOLOGY 
6.1 Study Design 
This is a randomised controlled trial, unblinded study. 
6.2 Study Population / Study Period  
This study included all patients who are scheduled for ESWL between 1st April 2012 
until 31st December 2012 in Urology Unit, Hospital Universiti Sains Malaysia, Kubang 
Kerian, Kelantan. 
6.3 Inclusion Criteria 
All patients with renal and ureteric stones scheduled for ESWL are included into this 
study 
6.4 Exclusion Criteria 
The following patients are excluded from study: 
(1) Patients who has symptomatic UTI before ESWL 
(2) Repeated patients for this study 
(3) Patients who are allergic to ciprofloxacin 
(4) Patients with recent antibiotic usage within 7 days from ESWL 
6.5 Sample Size Calculation 
6.5.1 Sample Size Calculation for Asymptomatic UTI Group 
Sample size calculation is estimated by two proportion chi-square test using Power and 
Sample Size Calculations ver 3.0 by William Dupont.  
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(Reference:  Deliveliotis, C., Giftopoulos, A., Koutsokalis, G., Raptidis, G. & 
Kostakopoulos, A. (1997). The necessity of prophylactic antibiotics during 
extracorporeal shock wave lithotripsy. International Urology and Nephrology, 29(5), 
517-521) 
α = 0.05  
Power = 0.8 
p0 = 0.21 (probability of UTI in no antibiotic group) 
p1 = 0.02 (probability of UTI in antibiotic prophylaxis group) 
m = 1 (ratio of no antibiotic group patients to antibiotic prophylaxis group patients) 
n = 43 per group 
Total n = [n x 4] + 10% (lost to follow-up) = 190 
Total sample size (n) needed: 190 
6.5.2 Sample Size Calculation for Sterile Urine Group 
Sample size calculation is estimated by two proportion chi-square test using Power and 
Sample Size Calculations ver 3.0 by William Dupont.  
(Reference: Knipper, A., Böhle, A., Pensel, J. & Hofstetter, A. (1989). Antibiotic 
prophylaxis with enoxacin in extracorporeal shockwave lithotripsy. Infection, 17, S37-
S38.) 
α = 0.05  
Power = 0.8 
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p0 = 0.32 (probability of UTI in no antibiotic group) 
p1 = 0.02 (probability of UTI in antibiotic prophylaxis group) 
m = 1 (ratio of no antibiotic group patients to antibiotic prophylaxis group patients) 
n = 23 per group 
Total n = [n x 4] + 10% (lost to follow-up) = 102 
Total sample size (n) needed: 102 
6.5.3 Sample Size Calculation for Prevalence of Asymptomatic UTI  
Sample size calculation is estimated by single proportion equation using EpiInfo ver 6. 
(Reference: Skolarikos, A., G. Alivizatos, et al. Extracorporeal shock wave lithotripsy 
25 years later: complications and their prevention. European urology 2006; 50(5): 981-
990.) 
Expected prevalence: 23.5% 
Worst acceptable prevalence: 30% 
With Confidence Interval of 95%, a sample size of 163 is required. 
Total n = n + 10% (loss to follow-up) = 180 
Total sample size (n) needed: 180 
In conclusion, the minimum sample size needed for this study is 190 (based on 
calculation of sample size for asymptomatic bacteriuria)  
  
